Metoprolol succinate

Product NDC: 55700-192
11-digit product format: 557000192
Labeler code: 55700
Product ID: 55700-192_3b3edb95-fb8e-4a45-8b2b-b96aa6234889
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Metoprolol succinate
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Quality Care Products LLC
Application: ANDA090617
Marketing category: ANDA
Marketing start: 2012-09-10
Marketing end: 0000-00-00
Substance: METOPROLOL SUCCINATE
Active strength: 50 mg/1
Pharmacologic classes: Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	55700-192		D	Discontinued by firm	2026-08-07
excluded package	package	55700-192	55700-192-30	D	Discontinued by firm	2026-08-07
excluded package	package	55700-192	55700-192-60	D	Discontinued by firm	2026-08-07
excluded package	package	55700-192	55700-192-90	D	Discontinued by firm	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 60 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55700-192-90	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55700-192-60	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55700-192-30	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55700-192-90	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55700-192-60	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55700-192-30	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55700-192-90	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55700-192-60	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55700-192-30	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55700-192-90	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55700-192-60	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55700-192-30	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55700-192-90	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55700-192-60	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55700-192-30	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55700-192-90	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55700-192-60	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55700-192-30	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55700-192-90	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55700-192-60	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55700-192-30	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55700-192-90	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55700-192-60	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55700-192-30	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55700-192-90	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55700-192-60	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55700-192-30	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55700-192-90	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55700-192-60	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55700-192-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55700-192-90	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55700-192-60	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55700-192-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55700-192-90	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55700-192-60	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55700-192-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	55700-192-90	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	55700-192-60	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	55700-192-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	55700-192-90	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	55700-192-60	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	55700-192-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	55700-192-90	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	55700-192-60	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	55700-192-30	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A090617-001	METOPROLOL SUCCINATE	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB		2012-08-01
A090617-002	METOPROLOL SUCCINATE	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB		2012-08-01

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A090617-001	AB
A090617-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A090617-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090617-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090617-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090617-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090617-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090617-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090617-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090617-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090617-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090617-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090617-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090617-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090617-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090617-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090617-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090617-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090617-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090617-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090617-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090617-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090617-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090617-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090617-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090617-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090617-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090617-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090617-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090617-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090617-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090617-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090617-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090617-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090617-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090617-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090617-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090617-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A090617-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A090617-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A090617-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A090617-002	AB	1	`782e0a99824c…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
55700-192-30	2025-01-08	These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 1992
55700-192-60	2025-01-08	These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 1992
55700-192-90	2025-01-08	These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 1992
55700-192-30	2024-01-30	These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 1992
55700-192-60	2024-01-30	These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 1992
55700-192-90	2024-01-30	These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 1992

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55700-192-30	EA - Each	55700-192	880987e2-0457-4c13-8ab2-80bd212937a3	1	2017-12-14
55700-192-60	EA - Each	55700-192	f7f71935-b656-46dc-9d19-50cef08f8295	1	2017-12-14
55700-192-90	EA - Each	55700-192	2e84794c-a44c-487b-b9e2-292db5ef5f67	1	2017-12-14

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 22 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Metoprolol succinate	METOPROLOL SUCCINATE	Aphena Pharma Solutions - Tennessee, LLC	522c40f2-80f1-e2fc-e063-6294a90ad091	2026-05-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Aphena Pharma Solutions - Tennessee, LLC	51b630c7-6c03-7876-e063-6294a90acb30	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol Succinate	METOPROLOL SUCCINATE	Cardinal Health 107, LLC	028049cd-d233-49f9-87fa-ec91e433a49f	2026-04-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Major Pharmaceuticals	14ab9921-4651-4abc-92dc-aab1719b6bb0	2026-03-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Dr. Reddy's Laboratories Inc	24c87741-ee0a-738e-2c5a-5ce80ca2f48b	2026-01-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	PD-Rx Pharmaceuticals, Inc.	4eea76dd-af6d-419a-90e4-ba9eff3b2c73	2025-10-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	PD-Rx Pharmaceuticals, Inc.	947f7982-2aea-40fb-a93b-c0a28f89da85	2025-10-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	A-S Medication Solutions	114346a1-ce49-49d2-9674-2fa6a49749c3	2025-09-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	A-S Medication Solutions	46c288aa-a55c-4207-9a6e-ceef3c2f60ff	2025-09-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	AvPAK	71b27b55-44aa-113d-e053-2995a90a1cf7	2025-08-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Cardinal Health 107, LLC	e2f8dd23-600f-460e-aced-4e13504628f1	2025-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Cardinal Health 107, LLC	1ab032d6-db68-4108-85d1-56e828d0dc01	2025-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Cardinal Health 107, LLC	f6689572-d53d-49eb-a932-85056612a355	2025-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Quallent Pharmaceuticals Health LLC	250c2428-c8b0-5156-697a-60cb8a45713c	2025-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Northstar Rx LLC	ad097646-cc77-8d67-5974-cc00060409f2	2025-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	NuCare Pharmaceutcals, Inc.	32341a31-a2db-cf13-e063-6394a90aad89	2025-04-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	NCS HealthCare of KY, LLC dba Vangard Labs	c4fb991c-025c-4a1d-9766-4b62ad70b5fe	2025-02-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol Succinate	METOPROLOL SUCCINATE	American Health Packaging	74e3b4dc-eb30-4d7c-a558-cf58f6470496	2024-09-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	A-S Medication Solutions	342846fb-d42f-4d96-a8b5-7bcf1dcaef2f	2024-03-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	A-S Medication Solutions	836c4a24-42f6-451a-8911-23444e01e5e8	2024-03-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
TH25PD4CCB	METOPROLOL SUCCINATE	98418-47-4	METOPROLOL SUCCINATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
55700-192-30	55700019230	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-192-30)	2014-12-12	0000-00-00	No	No	Current
55700-192-60	55700019260	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-192-60)	2014-12-12	0000-00-00	No	No	Current
55700-192-90	55700019290	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-192-90)	2014-12-12	0000-00-00	No	No	Current